| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-06 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.13 | 1e-05 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-05 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |